« previous next »
Pages: [1]

Author Topic: Randomized clinical trial: 2 fingolimod doses vs. Copaxone for patients with RRMS  (Read 62 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9841
  • MS diagnosed 1980
  • Location: Pacific Northwest
Randomized clinical trial: 2 fingolimod doses vs. Copaxone for patients with RRMS
« on: August 25, 2020, 09:15:13 pm »
From JAMA  (August 24, 2020)--"Efficacy and safety of 2 fingolimod doses vs. glatiramer acetate for the treatment of patients with relapsing-remitting multiple sclerosis: A randomized clinical trial":


https://bit.ly/3ldtkSB
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.
Pages: [1]
« previous next »
 

Related Topics